CAR T-Cell Therapy for Multiple Myeloma: BCMA Targets, Eligibility, Response and Side Effects | Next-Generation CAR T-Cell Therapy in Multipl

This video explains Next-Generation CAR T-Cell Therapy in Multiple Myeloma with a focused overview of multiple myeloma treatment, BCMA CAR T therapy, and proteasome inhibitors. Important topics include immunomodulatory drugs, monoclonal antibodies, and myeloma relapse, with practical context for diagnosis, treatment sequencing, expected outcomes, and follow-up. The video is especially relevant to people searching for multiple myeloma treatment, immunomodulatory drugs, or monoclonal antibodies and wanting a clearer explanation of how oncologists make treatment decisions. Designed to clarify complex oncology terminology and support informed conversations about diagnosis, treatment, and follow-up. Treatment plans vary with stage pathology molecular features prior therapy and